Clinical trials are essential to modern drug development. They provide scientific validation of a therapy’s safety, efficacy, and quality before patients receive it in clinical settings. Because trials must be conducted under strict regulatory oversight and ethical standards, they require coordinated operations—from protocol planning and patient enrollment to monitoring, data handling, and reporting. As a leading Contract Research Organization (CRO), the EPNextS Group supports pharmaceutical companies, biotechnology innovators, and healthcare institutions by delivering precise, efficient, and globally compliant clinical trial services.

In Japan, the EPNextS Group also fulfills the role of a Site Management Organization (SMO). Although the term “SMO” may be less common outside Japan, it plays a crucial role in the country’s trial infrastructure. EP-Link, our SMO subsidiary, supports hospitals and clinics nationwide, ensuring smooth site initiation, consistent patient enrollment, and accurate data collection. By providing hands-on operational support, EP-Link bridges the gap between detailed protocols and the realities of daily clinical practice.

By combining CRO strategies with SMO execution, the EPNextS Group offers a unified operational model that reduces delays, strengthens data reliability, and improves overall trial quality. This structure is especially valuable for multi-center studies, rare disease research, and specialized trials requiring close collaboration with healthcare professionals.